Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NTT (Nippon Telegraph and Telephone Corporation) is a global technology and telecommunications conglomerate that has established a significant presence in the life sciences and healthcare sectors through its advanced R&D initiatives. The company's healthcare strategy is centered on the "Bio-digital Twin" (BDT) technology, which utilizes high-performance computing and AI to create precise digital replicas of human physiology for disease simulation and treatment optimization. These efforts are primarily driven by the NTT Software Innovation Center and the Medical & Health Informatics Laboratories, which develop sophisticated software platforms for genomic analysis and cardiovascular modeling. Additionally, NTT operates NTT Life Science, a subsidiary focused on providing genomic data services and precision medicine solutions to improve population health. Through strategic collaborations with global academic and clinical institutions, NTT is advancing the integration of data science and medicine to deliver personalized healthcare insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NTT Software Innovation Program.